¼¼°èÀÇ ÀÇ·á±â±â ºÒ¸¸ °ü¸® ½ÃÀå
Medical Device Complaint Management
»óǰÄÚµå : 1787123
¸®¼­Ä¡»ç : Global Industry Analysts, Inc.
¹ßÇàÀÏ : 2025³â 08¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 187 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,850 £Ü 8,257,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 17,550 £Ü 24,771,000
PDF (Global License to Company and its Fully-owned Subsidiaries) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

¼¼°èÀÇ ÀÇ·á±â±â ºÒ¸¸ °ü¸® ½ÃÀåÀº 2030³â±îÁö 247¾ï ´Þ·¯¿¡ À̸¦ Àü¸Á

2024³â¿¡ 157¾ï ´Þ·¯·Î ÃßÁ¤µÇ´Â ÀÇ·á±â±â ºÒ¸¸ °ü¸® ¼¼°è ½ÃÀåÀº 2024-2030³â°£ CAGR 7.8%·Î ¼ºÀåÇÏ¿© 2030³â¿¡´Â 247¾ï ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. º» º¸°í¼­¿¡¼­ ºÐ¼®ÇÑ ºÎ¹® Áß ÇϳªÀÎ ºÒ¸¸ ·Î±×/Á¢¼ö´Â CAGR 9.5%¸¦ ³ªÅ¸³»°í, ºÐ¼® ±â°£ Á¾·á½Ã¿¡´Â 128¾ï ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. Á¦Ç° °¨½Ã ¹× ±ÔÁ¦ Áؼö ºÐ¾ßÀÇ ¼ºÀå·üÀº ºÐ¼® ±â°£Áß CAGR 5.8%·Î ÃßÁ¤µË´Ï´Ù.

¹Ì±¹ ½ÃÀåÀº 43¾ï ´Þ·¯·Î ÃßÁ¤¡¤Áß±¹Àº CAGR12.5%·Î ¼ºÀå ¿¹Ãø

¹Ì±¹ÀÇ ÀÇ·á±â±â ºÒ¸¸ °ü¸® ½ÃÀåÀº 2024³â¿¡ 43¾ï ´Þ·¯·Î ÃßÁ¤µË´Ï´Ù. ¼¼°è 2À§ °æÁ¦´ë±¹ÀÎ Áß±¹Àº 2030³â±îÁö 53¾ï ´Þ·¯ ±Ô¸ð¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, ºÐ¼® ±â°£ÀÎ 2024-2030³â CAGRÀº 12.5%·Î ÃßÁ¤µË´Ï´Ù. ±âŸ ÁÖ¸ñÇØ¾ß ÇÒ Áö¿ªº° ½ÃÀåÀ¸·Î´Â ÀϺ»°ú ij³ª´Ù°¡ ÀÖÀ¸¸ç, ºÐ¼® ±â°£Áß CAGRÀº °¢°¢ 3.8%¿Í 7.6%¸¦ º¸ÀÏ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. À¯·´¿¡¼­´Â µ¶ÀÏÀÌ CAGR 5.2%¸¦ ³ªÅ¸³¾ Àü¸ÁÀÔ´Ï´Ù.

¼¼°èÀÇ ÀÇ·á±â±â ºÒ¸¸ °ü¸® ½ÃÀå - ÁÖ¿ä µ¿Çâ°ú ÃËÁø¿äÀÎ Á¤¸®

ºÒ¸¸ °ü¸®°¡ ÀÇ·á±â±â ¾ÈÀüÀÇ Áß¿äÇÑ ÃàÀÌ µÇ°í ÀÖ´Â ÀÌÀ¯´Â ¹«¾ùÀϱî?

±ÔÁ¦°¡ °­È­µÇ°í °¨½ÃÀÇ ´«ÀÌ ³ô¾ÆÁö´Â ÇコÄÉ¾î ºÐ¾ß¿¡¼­ ÀÇ·á±â±â ºÎ¹®ÀÇ È¿°úÀûÀÎ ºÒ¸¸ °ü¸®´Â ´õ ÀÌ»ó ºÎÂ÷ÀûÀÎ °ü½É»ç°¡ ¾Æ´Ñ ¾÷¹«»ó ÇʼöÀûÀÎ »çÇ×ÀÔ´Ï´Ù. ÀÇ·á±â±âÀÇ »ç¿ëÀÌ ´õ¿í ±¤¹üÀ§ÇÏ°í °íµµÈ­µÊ¿¡ µû¶ó ¾ÈÀü, À¯È¿¼º ¹× ±ÔÁ¤ Áؼö¸¦ º¸ÀåÇÏ´Â °ÍÀÌ °¡Àå Áß¿äÇÑ °úÁ¦°¡ µÇ°í ÀÖ½À´Ï´Ù. ºÒ¸¸ °ü¸® ½Ã½ºÅÛÀº Á¦Ç° °áÇÔÀ» ½Äº°Çϰí, »ç¿ëÀÚ Çǵå¹éÀ» ÀÌÇØÇϸç, À§Çظ¦ ¿¹¹æÇϰí ȯÀÚ °á°ú¸¦ °³¼±Çϱâ À§ÇÑ ½ÃÁ¤ Á¶Ä¡¸¦ ½ÃÇàÇÏ´Â µ¥ Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. FDA(¹Ì±¹ ½ÄǰÀǾ౹)¿Í EMA(À¯·´ÀǾàǰû)¿Í °°Àº ±ÔÁ¦ ±â°üÀº ¾ö°ÝÇÑ ½ÃÆÇ ÈÄ Á¶»ç¿Í ºÎÀÛ¿ë º¸°í¸¦ Àǹ«È­Çϰí ÀÖÀ¸¸ç, ºÒ¸¸ 󸮴 ǰÁú °ü¸® ½Ã½ºÅÛÀÇ Áß¿äÇÑ ¿ä¼Ò·Î ÀÚ¸® Àâ°í ÀÖ½À´Ï´Ù.

ȯÀÚÀÇ ±Ç¸®¿Í Á¦Ç° Åõ¸í¼º¿¡ ´ëÇÑ Àü ¼¼°èÀûÀÎ ÀνÄÀÌ ³ô¾ÆÁü¿¡ µû¶ó ÀÇ·á Á¦°ø¾÷ü, ÆÇ¸Å¾÷ü, ȯÀÚ ¸ðµÎ »ç¼ÒÇÑ ±â±â ¹®Á¦µµ ½Å°íÇÏ´Â °æÇâÀÌ ³ô¾ÆÁö¸é¼­ ºÒ¸¸ÀÇ ¾ç°ú º¹À⼺ÀÌ ´õ¿í È®´ëµÇ°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ »óȲ¿¡¼­ °ß°íÇϰí Åõ¸íÇÑ µ¥ÀÌÅÍ ±â¹Ý ºÒ¸¸ °ü¸® ÇÁ·¹ÀÓ¿öÅ©¸¦ µµÀÔÇÏ´Â ±â¾÷Àº ¸®½ºÅ©¸¦ ÁÙÀ̰í, ºê·£µå ½Å·Ú¸¦ À¯ÁöÇϸç, ±ÔÁ¦ ŸÀÓ¶óÀÎÀ» ÁؼöÇÒ ¼ö ÀÖ´Â ´õ ³ªÀº ü°è¸¦ °®Ãß°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ºÒ¸¸ µ¥ÀÌÅÍ´Â ´õ ÀÌ»ó ´Ü¼øÇÑ ±ÔÁ¦ ¿ä°ÇÀÌ ¾Æ´Ï¶ó Á¦Ç° ¼³°è °³¼±, ¼Ò¼Û À§Çè °¨¼Ò, ½ÃÀå ÀçÆ÷Áö¼Å´×À» À§ÇÑ °¡À̵å¶óÀÎÀ» Á¦°øÇÏ´Â Àü·«Àû ÀÚ»êÀ¸·Î °£Áֵǰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Àü·«Àû Á߿伺ÀÌ ³ô¾ÆÁü¿¡ µû¶ó ÀÇ·á±â±â Á¦Á¶¾÷üµéÀº º¸´Ù Á¤±³ÇÑ ºÒ¸¸ ÃßÀû ¹× ÇØ°á µµ±¸¸¦ äÅÃÇϰí ÀÖÀ¸¸ç, Á¾Á¾ º¸´Ù ±¤¹üÀ§ÇÑ Ç°Áú °ü¸® ¹× °í°´ °ü°è Ç÷§Æû¿¡ ÅëÇյǾî ÀÖ½À´Ï´Ù.

µðÁöÅÐ µµ±¸¿Í AI°¡ ºÒ¸¸ ó¸® ÇÁ·Î¼¼½º¸¦ ¾î¶»°Ô º¯È­½Ã۰í Àִ°¡?

µðÁöÅÐ ÀüȯÀº ÀÇ·á±â±â Á¦Á¶¾÷ü°¡ ºÒ¸¸À» °ü¸®Çϰí ÇØ°áÇÏ´Â ¹æ¹ýÀ» ÀçÁ¤ÀÇÇϰí ÀÖ½À´Ï´Ù. Ŭ¶ó¿ìµå ±â¹Ý ºÒ¸¸ °ü¸® ½Ã½ºÅÛÀ» ÅëÇØ Àü ¼¼°è Á¦Á¶¾÷ü´Â ¿©·¯ Áö¿ª, »ç¾÷ºÎ, ÀåºñÀÇ ºÒ¸¸ µ¥ÀÌÅ͸¦ ÅëÇÕ ´ë½Ãº¸µå·Î ÀÏ¿øÈ­ÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ ÅëÇÕÀ» ÅëÇØ ¸ð´ÏÅ͸µÀÌ Çâ»óµÉ »Ó¸¸ ¾Æ´Ï¶ó ÃßÀû¼º ¹× °¨»ç¿¡ ´ëÇÑ ´ëÀÀ·Âµµ °­È­µË´Ï´Ù. ÀÌ Ç÷§ÆûÀº ºÒ¸¸ Á¢¼ö, ºÐ·ù, Á¶»ç, ÇØ°á, ½Ç½Ã°£ ¾Ë¸², ºÐ¼® ´ë½Ãº¸µå µî ÀÚµ¿È­ ¿öÅ©Ç÷ο츦 ÅëÇØ ¼öÀÛ¾÷ÀÇ ºÎ´ãÀ» ÁÙÀ̰í, °£°ú³ª Áö¿¬À¸·Î ÀÎÇÑ ÄÄÇöóÀ̾𽺠À§¹Ý À§ÇèÀ» ÃÖ¼ÒÈ­ÇÕ´Ï´Ù.

ÀΰøÁö´É(AI)°ú ¸Ó½Å·¯´×Àº ÆÐÅÏÀ» °¨ÁöÇÏ°í »õ·Î¿î À§ÇèÀ» ¿¹ÃøÇϱâ À§ÇØ ¹Î¿øÃ³¸® ½Ã½ºÅÛ¿¡ ÅëÇյǰí ÀÖ½À´Ï´Ù. ÀÚ¿¬¾î ó¸®(NLP) µµ±¸´Â °í°´ÀÇ À̸ÞÀÏ, ÅëÈ­ ±â·Ï, ¿Â¶óÀÎ ¸®ºä¿¡¼­ ºñÁ¤Çü ÅØ½ºÆ®¸¦ ºÐ¼®ÇÏ¿© ÀáÀçÀûÀÎ ±â±â ¹®Á¦¸¦ ÀÚµ¿À¸·Î ½Äº°ÇÒ ¼ö ÀÖ½À´Ï´Ù. ¿¹Ãø ºÐ¼®À» ÅëÇØ ǰÁúº¸ÁõÆÀÀº ½É°¢¼º, Àç¹ß °¡´É¼º, ±ÔÁ¦ È®´ë °¡´É¼º¿¡ µû¶ó ºÒ¸¸»çÇ×ÀÇ ¿ì¼±¼øÀ§¸¦ Á¤ÇÒ ¼ö ÀÖ½À´Ï´Ù. ±â¾÷ÀÚ¿ø°èȹ(ERP), ¹®¼­°ü¸®½Ã½ºÅÛ(DMS), Á¦Ç°¼ö¸íÁÖ±â°ü¸®(PLM) Ç÷§Æû µî ´Ù¸¥ ½Ã½ºÅÛ°úÀÇ ÅëÇÕÀ» ÅëÇØ µ¥ÀÌÅÍÀÇ ¿¬¼Ó¼º°ú ¸Æ¶ô¿¡ ±â¹ÝÇÑ ÀÇ»ç°áÁ¤ÀÌ ´õ¿í °­È­µÇ°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ±â¼úÀû Áøº¸´Â º¸´Ù ½Å¼ÓÇϰí Àϰü¼º ÀÖ°í Á¤È®ÇÑ ºÒ¸¸ ÇØ°áÀ» °¡´ÉÇÏ°Ô ÇÏ´Â µ¿½Ã¿¡ ¼¼°è ½ÃÀå¿¡¼­ÀÇ Á¦Ç° ¼º´ÉÀ» ´õ ±íÀÌ ÀÌÇØÇÒ ¼ö ÀÖ°Ô ÇØÁÝ´Ï´Ù.

¼¼°è ÁÖ¿ä »ç¿ëÀÚ ¹× ½ÃÀå »óȲÀº?

°í±Þ ºÒ¸¸ °ü¸® ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä´Â ´Ù±¹Àû Àåºñ Á¦Á¶¾÷ü¿¡¸¸ ±¹ÇѵÇÁö ¾Ê½À´Ï´Ù. ÀÇ·á±â±â °ü·Ã Áß¼Ò±â¾÷(SME), À§Å¹Á¦Á¶¾÷ü, ÆÇ¸Å¾÷ü, ¼­ºñ½º Á¦°ø¾÷ü´Â ÄÄÇöóÀ̾𽺠±â´ë¿¡ ºÎÀÀÇÏ°í ¾÷¹«»ó À§ÇèÀ» ÁÙÀ̱â À§ÇØ ºÒ¸¸Ã³¸® µµ±¸¿¡ ´ëÇÑ ÅõÀÚ¸¦ ´Ã¸®°í ÀÖ½À´Ï´Ù. ÀÇ·á±â±â¸¦ »ç¿ë, À¯Åë ¶Ç´Â Àç°¡°øÇÏ´Â ÀÇ·á½Ã¼³µµ ºÒ¸¸ º¸°í »ýŰèÀÇ ÀϺΰ¡ µÇ°í ÀÖÀ¸¸ç, ƯÈ÷ À¯·´¿¬ÇÕ(EU)°ú °°Àº Áö¿ª¿¡¼­´Â MDR(ÀÇ·á±â±â ±ÔÁ¦)ÀÌ ½ÃÇàµÈ ÀÌÈÄ ´õ¿í ¾ö°ÝÇÑ º¸°í ¿ä°ÇÀÌ Àû¿ëµÇ°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ÀÌÇØ°ü°èÀÚÀÇ È®´ë·Î ÀÎÇØ º¥´õµéÀº ´Ù¾çÇÑ ±Ô¸ð¿Í ±ÔÁ¦ ºÎ´ãÀ» °¡Áø Á¶Á÷¿¡ ´ëÀÀÇÒ ¼ö ÀÖ´Â È®Àå °¡´ÉÇϰí, ¸ðµâÈ­µÇ¾î ÀÖÀ¸¸ç, »ç¿ëÀÚ Ä£È­ÀûÀÎ ºÒ¸¸ °ü¸® ¼Ö·ç¼ÇÀ» °³¹ßÇØ¾ß ÇÕ´Ï´Ù.

¾Æ½Ã¾ÆÅÂÆò¾ç, ¶óƾ¾Æ¸Þ¸®Ä«, Áßµ¿ÀÇ ½ÅÈï ½ÃÀåµµ ÇöÁö ÀÇ·á±â±â »ý»êÀÌ Áõ°¡ÇÏ°í ±ÔÁ¦ ´ç±¹ÀÇ ½ÃÆÇ ÈÄ Á¶»ç ÇÁ·¹ÀÓ¿öÅ©°¡ °­È­µÇ¸é¼­ ¼ºÀå¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. À̵é Áö¿ªÀÇ Á¤ºÎ ¹× ÀÇ·á ±ÔÁ¦ ´ç±¹Àº Áö¿ª °íÀ¯ÀÇ ºÒ¸¸ ó¸® ÀýÂ÷ ¹× µðÁöÅÐ ÃßÀû¼ºÀ» Á¡Á¡ ´õ ¸¹ÀÌ ¿ä±¸Çϰí ÀÖÀ¸¸ç, À̴ ƯÁ¤ ÄÄÇöóÀ̾𽺠üÁ¦¿¡ ¸Â´Â ºÒ¸¸ °ü¸® Ç÷§Æû¿¡ ´ëÇÑ Áö¿ªÀû ¼ö¿ä¸¦ ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ¼ÒÇÁÆ®¿þ¾î °ø±Þ¾÷ü¿Í ±ÔÁ¦ ÄÁ¼³ÆÃ ȸ»çÀÇ ÆÄÆ®³Ê½ÊÀº Á¦Á¶¾÷ü°¡ ¿©·¯ °üÇұǿ¡ °ÉÄ£ º¹ÀâÇÑ ºÒ¸¸ ó¸® ¿ä±¸ »çÇ×À» Ž»öÇÏ´Â µ¥ µµ¿òÀ» ÁÖ°í ÀÖ½À´Ï´Ù. ƯÈ÷ À¯·´(GDPR(EU °³ÀÎÁ¤º¸º¸È£±ÔÁ¤))°ú ͏®Æ÷´Ï¾Æ(CCPA)¿Í °°Àº Áö¿ª¿¡¼­ µ¥ÀÌÅÍ ÇÁ¶óÀ̹ö½Ã ¹ýÀÌ °­È­µÊ¿¡ µû¶ó ºÒ¸¸ °ü¸® ¼Ö·ç¼ÇÀº ¾ÈÀüÇÑ µ¥ÀÌÅÍ Ã³¸® ¹× À͸íÈ­¸¦ º¸ÀåÇϱâ À§ÇØ ÀûÀÀÇÏ¿© ¼¼°è Á¦Ç° »óȲÀ» ´õ¿í Çü¼ºÇϰí ÀÖ½À´Ï´Ù.

ÀÇ·á±â±â ºÒ¸¸ °ü¸® ½ÃÀåÀÇ ±Þ¼ºÀå ¿øµ¿·ÂÀº?

ÀÇ·á±â±â ºÒ¸¸ °ü¸® ½ÃÀåÀÇ ¼ºÀåÀº ±ÔÁ¦ È®´ë, ±â¼ú ÅëÇÕ, ÇコÄÉ¾î ¹ë·ùüÀÎ Àü¹ÝÀÇ ºñÁî´Ï½º °üÇà º¯È­¿Í °ü·ÃµÈ ¿©·¯ ¿äÀο¡ ÀÇÇØ ÁÖµµµÇ°í ÀÖ½À´Ï´Ù. ÁÖ¿ä ÃËÁø¿äÀÎÀº ¼¼°è ±ÔÁ¦ ȯ°æÀÇ °­È­·Î, ±â°üµéÀÌ Á¾ÇÕÀûÀÌ°í ½Ç½Ã°£ÀûÀÎ ºÒ¸¸ ÃßÀû ¹× ½ÃÁ¤ Á¶Ä¡ º¸°í¸¦ Àǹ«È­ÇÏ´Â µî ±ÔÁ¦ ȯ°æÀÌ °­È­µÇ°í ÀÖ½À´Ï´Ù. ȯÀÚ Áß½ÉÀÇ °á°ú ±â¹Ý Ä¡·á ¸ðµ¨·ÎÀÇ ÀüȯÀ¸·Î °í°´ Çǵå¹é ¹× ½ÃÆÇ ÈÄ ±â±â °¨½ÃÀÇ Á߿伺ÀÌ Ä¿Áö°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ¿þ¾î·¯ºí Çコ ¸ð´ÏÅÍ, À̽ÄÇü ÀÇ·á±â±â, AI Áö¿ø Áø´Ü µµ±¸ µî º¹ÀâÇÑ ÀÇ·á±â±â Áõ°¡·Î ÀÎÇØ ½Ç½Ã°£ ¸ð´ÏÅ͸µ°ú ½Å¼ÓÇÑ ¹Î¿ø ÇØ°áÀº »çġǰÀÌ ¾Æ´Ñ ÇʼöǰÀÌ µÇ¾ú½À´Ï´Ù.

Á¦Á¶¾÷ü»Ó¸¸ ¾Æ´Ï¶ó ÀÇ·á ¼­ºñ½º Á¦°ø¾÷ü ¹× Á¦3ÀÚ ¹°·ù »ç¾÷ÀÚµµ Åõ¸íÇÑ ºÒ¸¸ ó¸® ½Ã½ºÅÛÀ» À¯ÁöÇØ¾ß Çϱ⠶§¹®¿¡ ÃÖÁ¾ ¿ëµµÀÇ ´Ù¾çÈ­µµ ¼ö¿ä¸¦ ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ¼ÒºñÀÚ Çൿµµ ÇѸòÀ» Çϰí ÀÖÀ¸¸ç, ȯÀÚ¿Í ÀÇ·á ¼­ºñ½º Á¦°ø¾÷ü°¡ µðÁöÅРä³ÎÀ» ÅëÇØ ¿ì·Á¸¦ Ç¥¸íÇÏ´Â °æ¿ì°¡ ´Ã°í Àֱ⠶§¹®¿¡ ±â¾÷Àº ¿©·¯ Ä¿¹Â´ÏÄÉÀÌ¼Ç Ç÷§Æû¿¡¼­ ºÒ¸¸À» ÃßÀûÇÏ°í ´ëÀÀÇØ¾ß ÇÕ´Ï´Ù. ±â¼ú Ãø¸é¿¡¼­´Â Ŭ¶ó¿ìµå ÀÎÇÁ¶ó, AI¸¦ Ȱ¿ëÇÑ ºÐ¼®, ±âÁ¸ ±â¾÷ ½Ã½ºÅÛ°úÀÇ ÅëÇÕ Ã¤ÅÃÀÌ µµÀÔ À庮À» ³·Ãß°í ¾÷¹« È¿À²¼ºÀ» ³ôÀ̰í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ÃÖ±Ù Á¦Ç° ¸®Äݰú Áý´Ü ¼Ò¼Û Áõ°¡·Î ÀÎÇØ ±â¾÷ÀÇ Àû±ØÀûÀÎ ¸®½ºÅ© °¨¼Ò¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁö°í ÀÖÀ¸¸ç, źźÇÑ ºÒ¸¸ °ü¸®°¡ ±â¾÷ Àü·«ÀÇ ÇÙ½ÉÀ¸·Î ÀÚ¸® Àâ°í ÀÖ½À´Ï´Ù. ¸¶Áö¸·À¸·Î, Á¦Ç°ÀÌ ºü¸£°Ô ±¹°æÀ» ³Ñ³ªµå´Â ÀÇ·á±â±â ½ÃÀåÀÇ ¼¼°èÈ­·Î ÀÎÇØ ´Ù±¹¾î, ´Ù±ÔÁ¦ ȯ°æ¿¡ ÀûÀÀÇÒ ¼ö ÀÖ´Â ºÒ¸¸Ã³¸® ½Ã½ºÅÛÀÌ ÇÊ¿äÇϸç, ±â¾÷ÀÌ ¼¼°è ÄÄÇöóÀ̾ð½º, Ã¥ÀÓ, °æÀïÀ» À¯ÁöÇÒ ¼ö ÀÖµµ·Ï Çϰí ÀÖ½À´Ï´Ù.

ºÎ¹®

¼­ºñ½º À¯Çü(ºÒ¸¸ ·Î±×/Á¢¼ö, Á¦Ç° °¨½Ã ¹× ±ÔÁ¤ Áؼö, ¹Ýǰ/ºñ¹Ýǰ Á¦Ç° ºÐ¼®, ÇØ°á ¹× Á¾°á)

Á¶»ç ´ë»ó ±â¾÷ ¿¹

AI ÅëÇÕ

Global Industry Analysts´Â À¯È¿ÇÑ Àü¹®°¡ ÄÁÅÙÃ÷¿Í AIÅø¿¡ ÀÇÇØ¼­, ½ÃÀå Á¤º¸¿Í °æÀï Á¤º¸¸¦ º¯ÇõÇϰí ÀÖ½À´Ï´Ù.

Global Industry Analysts´Â LLM³ª ¾÷°è °íÀ¯ SLM¸¦ Á¶È¸ÇÏ´Â ÀϹÝÀûÀÎ ±Ô¹ü¿¡ µû¸£´Â ´ë½Å¿¡, ºñµð¿À ±â·Ï, ºí·Î±×, °Ë»ö ¿£Áø Á¶»ç, ¹æ´ëÇÑ ¾çÀÇ ±â¾÷, Á¦Ç°/¼­ºñ½º, ½ÃÀå µ¥ÀÌÅÍ µî, Àü ¼¼°è Àü¹®°¡·ÎºÎÅÍ ¼öÁýÇÑ ÄÁÅÙÃ÷ ¸®Æ÷ÁöÅ丮¸¦ ±¸ÃàÇß½À´Ï´Ù.

°ü¼¼ ¿µÇâ °è¼ö

Global Industry Analysts´Â º»»ç ¼ÒÀçÁö, Á¦Á¶°ÅÁ¡, ¼öÃâÀÔ(¿ÏÁ¦Ç° ¹× OEM)À» ±âÁØÀ¸·Î ±â¾÷ÀÇ °æÀï·Â º¯È­¸¦ ¿¹ÃøÇß½À´Ï´Ù. ÀÌ·¯ÇÑ º¹ÀâÇÏ°í ´Ù¸éÀûÀÎ ½ÃÀå ¿ªÇÐÀº ¼öÀÍ¿ø°¡(COGS) Áõ°¡, ¼öÀͼº Ç϶ô, °ø±Þ¸Á ÀçÆí µî ¹Ì½ÃÀû, °Å½ÃÀû ½ÃÀå ¿ªÇÐ Áß¿¡¼­µµ ƯÈ÷ °æÀï»çµé¿¡°Ô ¿µÇâÀ» ¹ÌÄ¥ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ½ÃÀå ºÐ¼®

Á¦4Àå °æÀï

LSH
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Medical Device Complaint Management Market to Reach US$24.7 Billion by 2030

The global market for Medical Device Complaint Management estimated at US$15.7 Billion in the year 2024, is expected to reach US$24.7 Billion by 2030, growing at a CAGR of 7.8% over the analysis period 2024-2030. Complaints Log / Intake, one of the segments analyzed in the report, is expected to record a 9.5% CAGR and reach US$12.8 Billion by the end of the analysis period. Growth in the Product Surveillance & Regulatory Compliance segment is estimated at 5.8% CAGR over the analysis period.

The U.S. Market is Estimated at US$4.3 Billion While China is Forecast to Grow at 12.5% CAGR

The Medical Device Complaint Management market in the U.S. is estimated at US$4.3 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$5.3 Billion by the year 2030 trailing a CAGR of 12.5% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.8% and 7.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 5.2% CAGR.

Global Medical Device Complaint Management Market - Key Trends & Drivers Summarized

Why Is Complaint Management Becoming a Critical Pillar in Medical Device Safety?

In the increasingly regulated and scrutinized landscape of healthcare, effective complaint management in the medical device sector is no longer a secondary concern-it’s an operational imperative. As the use of medical devices becomes more widespread and sophisticated, ensuring their safety, efficacy, and compliance is paramount. Complaint management systems play a vital role in identifying product flaws, understanding user feedback, and implementing corrective actions to prevent harm and enhance patient outcomes. Regulatory agencies such as the FDA (U.S. Food and Drug Administration) and the European Medicines Agency (EMA) mandate strict post-market surveillance and adverse event reporting, making complaint handling a critical component of quality management systems.

With rising global awareness about patient rights and product transparency, healthcare providers, distributors, and patients alike are increasingly reporting even minor device issues, further expanding the volume and complexity of complaints. In this context, companies that implement robust, transparent, and data-driven complaint management frameworks are better equipped to mitigate risks, maintain brand trust, and comply with regulatory timelines. Moreover, complaint data is no longer viewed merely as a regulatory requirement but as a strategic asset that can inform product design improvements, reduce litigation exposure, and guide market repositioning efforts. This growing strategic importance is pushing medical device manufacturers to adopt more sophisticated complaint tracking and resolution tools, often embedded within broader quality management or customer relationship platforms.

How Are Digital Tools and AI Transforming Complaint Handling Processes?

Digital transformation is redefining how medical device companies manage and resolve complaints, shifting from reactive processes to proactive, real-time solutions. Cloud-based complaint management systems are enabling global manufacturers to centralize complaint data from multiple regions, business units, and devices into a unified dashboard. This consolidation not only improves oversight but also enhances traceability and audit readiness. These platforms come equipped with automated workflows, real-time alerts, and analytics dashboards that streamline the intake, triage, investigation, and resolution of complaints, reducing manual workload and minimizing the risk of non-compliance due to oversight or delay.

Artificial Intelligence (AI) and machine learning are increasingly being integrated into complaint systems to detect patterns and predict emerging risks. Natural language processing (NLP) tools can analyze unstructured text from customer emails, call transcripts, or online reviews to automatically identify potential device issues. Predictive analytics can help quality assurance teams prioritize complaints based on severity, recurrence, or potential for regulatory escalation. Integration with other systems such as Enterprise Resource Planning (ERP), Document Management Systems (DMS), and Product Lifecycle Management (PLM) platforms is further enhancing data continuity and contextual decision-making. These technological advancements are enabling faster, more consistent, and more accurate complaint resolution, while simultaneously providing a deeper understanding of product performance across global markets.

Who Are the Key Users and How Is the Market Landscape Evolving Globally?

The demand for advanced complaint management solutions is not confined to multinational device manufacturers alone. Small and medium-sized enterprises (SMEs), contract manufacturers, distributors, and even service providers involved in medical device operations are increasingly investing in complaint handling tools to meet compliance expectations and reduce operational risks. Hospitals and healthcare facilities that use, distribute, or reprocess medical devices are also becoming part of the complaint reporting ecosystem, particularly under stricter reporting requirements in regions like the European Union post-MDR (Medical Device Regulation) implementation. This expansion of the stakeholder base is pushing vendors to develop complaint management solutions that are scalable, modular, and user-friendly, accommodating organizations of various sizes and regulatory burdens.

Emerging markets in Asia-Pacific, Latin America, and the Middle East are also contributing to growth, as local medical device production rises and regulatory bodies strengthen post-market surveillance frameworks. Governments and healthcare regulators in these regions are increasingly requiring localized complaint handling procedures and digital traceability, fostering regional demand for complaint management platforms tailored to specific compliance regimes. Moreover, partnerships between software vendors and regulatory consultancy firms are helping manufacturers navigate complex complaint handling requirements across multiple jurisdictions. As data privacy laws become stricter, especially in regions like Europe (GDPR) and California (CCPA), complaint management solutions are being adapted to ensure secure data handling and anonymization, further shaping the global product landscape.

What’s Driving the Rapid Growth in the Medical Device Complaint Management Market?

The growth in the medical device complaint management market is driven by several factors tied to regulatory expansion, technological integration, and shifting business practices across the healthcare value chain. A key driver is the intensifying global regulatory environment, with agencies mandating comprehensive, real-time complaint tracking and corrective action reporting. The transition to more patient-centric and outcomes-based care models is increasing the importance of customer feedback and post-market device surveillance. Additionally, the rising volume of complex medical devices, including wearable health monitors, implantables, and AI-assisted diagnostic tools, has made real-time monitoring and rapid complaint resolution a necessity, not a luxury.

End-use diversification is also fueling demand, as not only manufacturers but also healthcare providers and third-party logistics players are required to maintain transparent complaint handling systems. Consumer behavior is playing a role, too, with patients and providers increasingly voicing concerns through digital channels, which requires companies to track and respond to complaints across multiple communication platforms. On the technology front, the adoption of cloud infrastructure, AI-powered analytics, and integration with existing enterprise systems is lowering implementation barriers and enhancing operational efficiency. Furthermore, increased product recalls and class-action lawsuits in recent years have heightened corporate focus on proactive risk mitigation, placing robust complaint management at the core of enterprise strategy. Lastly, the globalization of the medical device market-with products crossing borders rapidly-demands complaint handling systems that can adapt to multilingual, multi-regulatory environments, ensuring that companies remain compliant, accountable, and competitive worldwide.

SCOPE OF STUDY:

The report analyzes the Medical Device Complaint Management market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Service Type (Complaints Log / Intake, Product Surveillance & Regulatory Compliance, Returned / Non-Returned Product Analysis, Resolve & Closure)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 43 Featured) -

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

III. MARKET ANALYSIS

IV. COMPETITION

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â